Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $379.77 Million |
|---|---|
| Enterprise Value | $1.62 Billion |
| Earnings per Share | $0.48 |
| Beta | -0.1 |
| Outstanding Shares | 45,536,256 |
| P/E Ratio | 14.25 |
|---|---|
| PEG | 5.81 |
| Price to Sales | 0.21 |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | 0.89 |
| Enterprise Value to EBIT | 18.44 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0.79 |
| Debt to Equity | 1.76 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Indrayani Biotech Ltd. conducts its business across a wide array of sectors, including Food and Hospitality, Dairy, Healthcare and Pharmaceuticals, Engineering, Biotechnology, Agriculture, and Infrastructure. The company organizes its op...